|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 113, Issue 3 439-450, Copyright © 2000 by Company of Biologists
JOURNAL ARTICLES |
DP Thomas, A Sunters, A Gentry and AE Grigoriadis
Department of Orthodontics, King's College London, Guy's Hospital, London Bridge, London SE1 9RT, UK.
We have investigated the role of c-Fos in chondrocyte differentiation in vitro using both constitutive and inducible overexpression approaches in ATDC5 chondrogenic cells, which undergo a well-defined sequence of differentiation from chondroprogenitors to fully differentiated hypertrophic chondrocytes. Initially, we constitutively overexpressed exogenous c-fos in ATDC5 cells. Several stable clones expressing high levels of exogenous c-fos were isolated and those also expressing the cartilage marker type II collagen showed a marked decrease in cartilage nodule formation. To investigate further whether c-Fos directly regulates cartilage differentiation independently of potential clonal variation, we generated additional clones in which exogenous c-fos expression was tightly controlled by a tetracycline-regulatable promoter. Two clones, DT7.1 and DT12.4 were capable of nodule formation in the absence of c-fos. However, upon induction of exogenous c-fos, differentiation was markedly reduced in DT7.1 cells and was virtually abolished in clone DT12.4. Pulse experiments indicated that induction of c-fos only at early stages of proliferation/differentiation inhibited nodule formation, and limiting dilution studies suggested that overexpression of c-fos decreased the frequency of chondroprogenitor cells within the clonal population. Interestingly, rates of proliferation and apoptosis were unaffected by c-fos overexpression under standard conditions, suggesting that these processes do not contribute to the observed inhibition of differentiation. Finally, gene expression analyses demonstrated that the expression of the cartilage markers type II collagen and PTH/PTHrP receptor were down-regulated in the presence of exogenous c-Fos and correlated well with the differentiation status. Moreover, induction of c-fos resulted in the concomitant increase in the expression of fra-1 and c-jun, further highlighting the importance of AP-1 transcription factors in chondrocyte differentiation. These data demonstrate that c-fos overexpression directly inhibits chondrocyte differentiation in vitro, and therefore these cell lines provide very useful tools for identifying novel c-Fos-responsive genes that regulate the differentiation and activity of chondrocytes.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Lago, R. Gomez, C. Dieguez, J. J Gomez-Reino, F. Lago, and O. Gualillo Unlike ghrelin, obestatin does not exert any relevant activity in chondrocytes Ann Rheum Dis, October 1, 2007; 66(10): 1399 - 1400. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schmidl, N. Adam, C. Surmann-Schmitt, T. Hattori, M. Stock, U. Dietz, B. de Crombrugghe, E. Poschl, and K. von der Mark Twisted Gastrulation Modulates Bone Morphogenetic Protein-induced Collagen II and X Expression in Chondrocytes in Vitro and in Vivo J. Biol. Chem., October 20, 2006; 281(42): 31790 - 31800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Papachristou, P. Pirttiniemi, T. Kantomaa, N. Agnantis, and E. K. Basdra Fos- and Jun-related transcription factors are involved in the signal transduction pathway of mechanical loading in condylar chondrocytes Eur J Orthod, February 1, 2006; 28(1): 20 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-G. Hwang, S.-S. Yu, H. Poo, and J.-S. Chun c-Jun/Activator Protein-1 Mediates Interleukin-1{beta}-induced Dedifferentiation but Not Cyclooxygenase-2 Expression in Articular Chondrocytes J. Biol. Chem., August 19, 2005; 280(33): 29780 - 29787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Magee, M. Nurminskaya, L. Faverman, P. Galera, and T. F. Linsenmayer SP3/SP1 Transcription Activity Regulates Specific Expression of Collagen Type X in Hypertrophic Chondrocytes J. Biol. Chem., July 8, 2005; 280(27): 25331 - 25338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Karreth, A. Hoebertz, H. Scheuch, R. Eferl, and E. F. Wagner The AP1 transcription factor Fra2 is required for efficient cartilage development Development, November 15, 2004; 131(22): 5717 - 5725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sunters, D. P. Thomas, W. A. Yeudall, and A. E. Grigoriadis Accelerated Cell Cycle Progression in Osteoblasts Overexpressing the c-fos Proto-oncogene: INDUCTION OF CYCLIN A AND ENHANCED CDK2 ACTIVITY J. Biol. Chem., March 12, 2004; 279(11): 9882 - 9891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Scheijen, M. Bronk, T. van der Meer, and R. Bernards Constitutive E2F1 Overexpression Delays Endochondral Bone Formation by Inhibiting Chondrocyte Differentiation Mol. Cell. Biol., May 15, 2003; 23(10): 3656 - 3668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E F Wagner Functions of AP1 (Fos/Jun) in bone development Ann Rheum Dis, November 1, 2002; 61(90002): ii40 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Newman, L. I. Gigout, L. Sudre, M. E. Grant, and G. A. Wallis Coordinated expression of matrix Gla protein is required during endochondral ossification for chondrocyte survival J. Cell Biol., August 6, 2001; 154(3): 659 - 666. [Abstract] [Full Text] [PDF]
|
|
